Assignee
TESARO INC
US·16 granted patents·21 pending applications·17 citations·filing 2012–2025
Top patents by PatentIndex Score
37 records- 0186US12527780B2Methods of treating ovarian cancerTESARO INC·Filed 2023·Granted Jan 20, 2026·0 cites·13 claims
- 0286US11091459B2Niraparib compositionsTESARO INC·Filed 2019·Granted Aug 17, 2021·3 cites·30 claims
- 0384US11661453B2Combination therapies for treating cancer with niraparib and PD-1 inhibitorsTESARO INC·Filed 2018·Granted May 30, 2023·3 cites·6 claims
- 0482US11407830B2Methods of treating cancer with anti-PD-1 antibodiesTESARO INC·Filed 2018·Granted Aug 9, 2022·3 cites·16 claims
- 0581US11622961B2Combination therapies for treating cancerTESARO INC·Filed 2018·Granted Apr 11, 2023·2 cites·10 claims
- 0679US11730725B2Niraparib formulationsTESARO INC·Filed 2018·Granted Aug 22, 2023·2 cites·15 claims
- 0777US2022395493A1Methods of Treating Ovarian CancerTESARO INC·Filed 2022·Application pending·0 cites
- 0877US2022175752A1Methods of Treating Ovarian CancerTESARO INC·Filed 2022·Application pending·0 cites
- 0976US2022175751A1Methods of Treating Ovarian CancerTESARO INC·Filed 2022·Application pending·0 cites
- 1075US11801240B2Combination therapies and uses thereofTESARO INC·Filed 2018·Granted Oct 31, 2023·1 cites·31 claims
- 1174US11926665B2Methods of treating cancer with anti-TIM-3 antibodiesTESARO INC·Filed 2018·Granted Mar 12, 2024·2 cites·13 claims
- 1273US11161834B2Methods of manufacturing of niraparibTESARO INC·Filed 2018·Granted Nov 2, 2021·1 cites·7 claims
- 1373US2023416223A1Niraparib CompositionsTESARO INC·Filed 2023·Application pending·0 cites
- 1471US12383542B2Methods of treating ovarian cancerTESARO INC·Filed 2018·Granted Aug 12, 2025·0 cites·22 claims
- 1571US2025387476A1Methods of Treating CancerTESARO INC·Filed 2025·Application pending·0 cites
- 1670US2024226082A1Combination therapies for treating cancerTESARO INC·Filed 2023·Application pending·0 cites
- 1768US12415855B2Methods of treating cancer with anti-PD-1 antibodiesTESARO INC·Filed 2022·Granted Sep 16, 2025·0 cites·12 claims
- 1868US11673877B2Niraparib compositionsTESARO INC·Filed 2021·Granted Jun 13, 2023·0 cites·20 claims
- 1965US2021346497A1Methods of Treating CancerTESARO INC·Filed 2019·Application pending·0 cites
- 2065US2024301057A1Methods of treating cancer with anti-tim-3 antibodiesTESARO INC·Filed 2024·Application pending·0 cites
- 2165US2024158495A1Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-3) and Uses ThereofTESARO INC·Filed 2023·Application pending·0 cites
- 2264US11629137B2Methods of manufacturing of niraparibTESARO INC·Filed 2021·Granted Apr 18, 2023·0 cites·14 claims
- 2364US2024082231A1Niraparib formulationsTESARO INC·Filed 2023·Application pending·0 cites
- 2461US2022089739A1Antibodies Directed Against Programmed Death-1 (PD-1)TESARO INC·Filed 2021·Application pending·0 cites
- 2561US2024366584A1Combination treatment of cancer with a parp inhibitor and a lipophilic statinTESARO INC·Filed 2022·Application pending·0 cites
- 2659US2021038585A1Niraparib formulationsTESARO INC·Filed 2020·Application pending·0 cites
- 2759US2026083839A1Methods of treating non-small cell lung cancer with anti-pd-1-antibodiesTESARO INC·Filed 2023·Application pending·0 cites
- 2853US2022135670A1Antibody agents directed against lymphocyte activation gene-3 (lag-3) and uses thereofTESARO INC·Filed 2018·Application pending·0 cites
- 2951US12297184B2Niraparib saltsTESARO INC·Filed 2019·Granted May 13, 2025·0 cites·15 claims
- 3051US2020016142A1Niraparib formulationsTESARO INC·Filed 2019·Application pending·0 cites
- 3145US2025352534A1Use of Niraparib for the Treatment of Brain CancerTESARO INC·Filed 2023·Application pending·0 cites
- 3243US2021106574A1Methods of Treating CancerTESARO INC·Filed 2018·Application pending·0 cites
- 3342US12156872B2Combination therapies for treating cancerTESARO INC·Filed 2018·Granted Dec 3, 2024·0 cites·24 claims
- 3442US2021030735A1Pediatric niraparib formulations and pediatric treatment methodsTESARO INC·Filed 2019·Application pending·0 cites
- 3541US12597519B2Methods for characterizing and treating a cancer type using cancer imagesTESARO INC·Filed 2020·Granted Apr 7, 2026·0 cites·18 claims
- 3640US2015306086A1Modulating certain tyrosine kinasesTESARO INC·Filed 2012·Application pending·0 cites
- 3736US2023059341A1Biopharmaceutical compositions and related methodsTESARO INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →